Glaucoma 360 panelist shares industry update on new drugs, drops

April 15, 2019

Ellie Chabi, MD, Therapeutic Area Head for Glaucoma & Neuroprotection and Lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, provides an update on its glaucoma pipeline.

Ellie Chabi, MD, is Therapeutic Area Head for Glaucoma & Neuroprotection, Lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insights from the industry panel discussion, "Drugs and Drops" at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.